Back to Archived Journals » Core Evidence » Volume 6

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Total article views   HTML views PDF downloads Totals
16,886 Dovepress* 11,837+ 4,742 16,579
PubMed Central* 5,049 1,451 6,500
Totals 16,886 6,193 23,079
*Since 4 April 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar